Vivos Therapeutics, Inc. (VVOS) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $17.44M | +16.0% |
| 2024 | $15.03M | +8.9% |
| 2023 | $13.80M | -13.9% |
| 2022 | $16.02M | -5.1% |
| 2021 | $16.89M | +29.2% |
| 2020 | $13.07M | +14.7% |
| 2019 | $11.39M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $17.44M | +16.0% |
| 2024 | $15.03M | +8.9% |
| 2023 | $13.80M | -13.9% |
| 2022 | $16.02M | -5.1% |
| 2021 | $16.89M | +29.2% |
| 2020 | $13.07M | +14.7% |
| 2019 | $11.39M | — |